Addition to "Designing Functionally Selective Noncatechol Dopamine D1 Receptor Agonists with Potent In Vivo Antiparkinsonian Activity".
Publication
, Journal Article
Martini, ML; Ray, C; Yu, X; Liu, J; Pogorelov, VM; Wetsel, WC; Huang, X-P; McCorvy, JD; Caron, MG; Jin, J
Published in: ACS Chem Neurosci
April 21, 2021
Duke Scholars
Published In
ACS Chem Neurosci
DOI
EISSN
1948-7193
Publication Date
April 21, 2021
Volume
12
Issue
8
Start / End Page
1464
Location
United States
Related Subject Headings
- 3404 Medicinal and biomolecular chemistry
- 3401 Analytical chemistry
- 3101 Biochemistry and cell biology
- 0304 Medicinal and Biomolecular Chemistry
Citation
APA
Chicago
ICMJE
MLA
NLM
Martini, M. L., Ray, C., Yu, X., Liu, J., Pogorelov, V. M., Wetsel, W. C., … Jin, J. (2021). Addition to "Designing Functionally Selective Noncatechol Dopamine D1 Receptor Agonists with Potent In Vivo Antiparkinsonian Activity". ACS Chem Neurosci, 12(8), 1464. https://doi.org/10.1021/acschemneuro.1c00186
Martini, Michael L., Caroline Ray, Xufen Yu, Jing Liu, Vladimir M. Pogorelov, William C. Wetsel, Xi-Ping Huang, John D. McCorvy, Marc G. Caron, and Jian Jin. “Addition to "Designing Functionally Selective Noncatechol Dopamine D1 Receptor Agonists with Potent In Vivo Antiparkinsonian Activity".” ACS Chem Neurosci 12, no. 8 (April 21, 2021): 1464. https://doi.org/10.1021/acschemneuro.1c00186.
Martini ML, Ray C, Yu X, Liu J, Pogorelov VM, Wetsel WC, et al. Addition to "Designing Functionally Selective Noncatechol Dopamine D1 Receptor Agonists with Potent In Vivo Antiparkinsonian Activity". ACS Chem Neurosci. 2021 Apr 21;12(8):1464.
Martini, Michael L., et al. “Addition to "Designing Functionally Selective Noncatechol Dopamine D1 Receptor Agonists with Potent In Vivo Antiparkinsonian Activity".” ACS Chem Neurosci, vol. 12, no. 8, Apr. 2021, p. 1464. Pubmed, doi:10.1021/acschemneuro.1c00186.
Martini ML, Ray C, Yu X, Liu J, Pogorelov VM, Wetsel WC, Huang X-P, McCorvy JD, Caron MG, Jin J. Addition to "Designing Functionally Selective Noncatechol Dopamine D1 Receptor Agonists with Potent In Vivo Antiparkinsonian Activity". ACS Chem Neurosci. 2021 Apr 21;12(8):1464.
Published In
ACS Chem Neurosci
DOI
EISSN
1948-7193
Publication Date
April 21, 2021
Volume
12
Issue
8
Start / End Page
1464
Location
United States
Related Subject Headings
- 3404 Medicinal and biomolecular chemistry
- 3401 Analytical chemistry
- 3101 Biochemistry and cell biology
- 0304 Medicinal and Biomolecular Chemistry